Outpatient metformin treatment reduces incidence of long COVID
Jun 12, 2023
The beneficial effect of metformin was consistent across subgroups.
10 percent of new drugs approved without meeting primary efficacy end points
Feb 14, 2023
The findings were seen for 21 drug approvals between 2018 and 2021, with only one-third needing postmarketing studies.
Solriamfetol effective for managing ADHD in adults
Oct 17, 2023
Solriamfetol was found to be well-tolerated with no significant effect on mean heart rate or systolic or diastolic blood pressure.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Diabetes drug maker sues over compounded versions of Mounjaro
Sep 20, 2023
The lawsuits are meant to stop the other companies from “the unlawful marketing and sale of non-FDA approved compounded products.”
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
DEA extends telemedicine for prescribing controlled meds as pandemic measures end
May 10, 2023
The extension through Nov. 11 gives the DEA and HHS a chance to consider revisions and public comments regarding proposals offered March 1.
US medical drug shortages reach record high
Apr 15, 2024
Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.